vs
Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and TOOTSIE ROLL INDUSTRIES INC (TR). Click either name above to swap in a different company.
TOOTSIE ROLL INDUSTRIES INC is the larger business by last-quarter revenue ($196.3M vs $158.6M, roughly 1.2× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 14.7%, a 56.5% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 1.5%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $61.0M).
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
STOK vs TR — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.6M | $196.3M |
| Net Profit | $112.9M | $28.8M |
| Gross Margin | — | 35.7% |
| Operating Margin | 70.2% | 17.0% |
| Net Margin | 71.2% | 14.7% |
| Revenue YoY | 3661.1% | 1.5% |
| Net Profit YoY | 528.0% | 27.9% |
| EPS (diluted) | $1.90 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $196.3M | ||
| Q3 25 | — | $232.7M | ||
| Q2 25 | — | $155.1M | ||
| Q1 25 | $158.6M | $148.5M | ||
| Q4 24 | $22.6M | $193.4M | ||
| Q3 24 | — | $225.9M | ||
| Q2 24 | — | $150.7M | ||
| Q1 24 | — | $153.2M |
| Q4 25 | — | $28.8M | ||
| Q3 25 | — | $35.7M | ||
| Q2 25 | — | $17.5M | ||
| Q1 25 | $112.9M | $18.1M | ||
| Q4 24 | $-10.5M | $22.5M | ||
| Q3 24 | — | $32.8M | ||
| Q2 24 | — | $15.6M | ||
| Q1 24 | — | $15.8M |
| Q4 25 | — | 35.7% | ||
| Q3 25 | — | 34.1% | ||
| Q2 25 | — | 36.4% | ||
| Q1 25 | — | 35.3% | ||
| Q4 24 | — | 39.1% | ||
| Q3 24 | — | 34.1% | ||
| Q2 24 | — | 33.5% | ||
| Q1 24 | — | 32.7% |
| Q4 25 | — | 17.0% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | 70.2% | 15.5% | ||
| Q4 24 | -60.4% | 20.0% | ||
| Q3 24 | — | 15.6% | ||
| Q2 24 | — | 10.2% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | — | 14.7% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 11.3% | ||
| Q1 25 | 71.2% | 12.2% | ||
| Q4 24 | -46.4% | 11.6% | ||
| Q3 24 | — | 14.5% | ||
| Q2 24 | — | 10.4% | ||
| Q1 24 | — | 10.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.90 | — | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.8M | $176.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $350.1M | $941.0M |
| Total Assets | $406.9M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $176.6M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $170.5M | ||
| Q1 25 | $274.8M | $176.6M | ||
| Q4 24 | $128.0M | $194.6M | ||
| Q3 24 | — | $163.2M | ||
| Q2 24 | — | $131.2M | ||
| Q1 24 | — | $159.4M |
| Q4 25 | — | $941.0M | ||
| Q3 25 | — | $918.9M | ||
| Q2 25 | — | $893.1M | ||
| Q1 25 | $350.1M | $879.4M | ||
| Q4 24 | $229.0M | $870.7M | ||
| Q3 24 | — | $870.2M | ||
| Q2 24 | — | $841.4M | ||
| Q1 24 | — | $834.4M |
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | $406.9M | $1.1B | ||
| Q4 24 | $271.6M | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.8M | $73.3M |
| Free Cash FlowOCF − Capex | $131.7M | $61.0M |
| FCF MarginFCF / Revenue | 83.0% | 31.1% |
| Capex IntensityCapex / Revenue | 0.1% | 6.3% |
| Cash ConversionOCF / Net Profit | 1.17× | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $96.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $73.3M | ||
| Q3 25 | — | $62.2M | ||
| Q2 25 | — | $-8.5M | ||
| Q1 25 | $131.8M | $3.6M | ||
| Q4 24 | $-23.2M | $68.8M | ||
| Q3 24 | — | $61.3M | ||
| Q2 24 | — | $-12.6M | ||
| Q1 24 | — | $21.4M |
| Q4 25 | — | $61.0M | ||
| Q3 25 | — | $50.7M | ||
| Q2 25 | — | $-16.0M | ||
| Q1 25 | $131.7M | $750.0K | ||
| Q4 24 | $-23.2M | $64.7M | ||
| Q3 24 | — | $55.8M | ||
| Q2 24 | — | $-16.6M | ||
| Q1 24 | — | $16.9M |
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | -10.3% | ||
| Q1 25 | 83.0% | 0.5% | ||
| Q4 24 | -102.7% | 33.5% | ||
| Q3 24 | — | 24.7% | ||
| Q2 24 | — | -11.0% | ||
| Q1 24 | — | 11.0% |
| Q4 25 | — | 6.3% | ||
| Q3 25 | — | 5.0% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | 0.1% | 1.9% | ||
| Q4 24 | 0.2% | 2.1% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | — | 2.9% |
| Q4 25 | — | 2.55× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | 1.17× | 0.20× | ||
| Q4 24 | — | 3.06× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | -0.81× | ||
| Q1 24 | — | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STOK
Segment breakdown not available.
TR
| Products | $194.3M | 99% |
| Rental And Royalty | $1.9M | 1% |
